CLYM ▼ -3.3% - Climb Bio, Inc. $CLYM - Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026 24-OCT-2026 07:30 PM ET